Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis

This publication has 51 references indexed in Scilit:

• Autoantibodies Against Oxidized Low-Density Lipoprotein and Cardiolipin in Patients With Coronary Heart Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus
  Arthritis & Rheumatism, 1999
• Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• High Prevalence of Anti-β2 Glycoprotein I Antibodies in Patients with Ischemic Heart Disease
  Autoimmunity, 1999
• Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis
  American Heart Journal, 1996
• Monoclonal anticardiolipin autoantibodies established from the (new zealand white x bxsb)f₁ mouse model of antiphospholipid syndrome cross‐react with oxidized low‐density lipoprotein
  Arthritis & Rheumatism, 1995
• Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• The oxidation hypothesis of atherosclerosis
  The Lancet, 1994
• Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).
  Journal of Clinical Investigation, 1992